In the years immediately following the IOMs 1998 report setting the current RDA, research associated an abnormally high level of homocysteine, a molecule involved in protein metabolism, with an increased risk of cardiovascular disease, mortality, and cognitive impairment
This helps you identify when symptoms are unrelated to the peptide and need investigation elsewhere
Not the extreme kind, but a
It requires understanding the regulatory landscape that made this formulation necessary, the molecular mechanisms that make it effective, and the practical protocols that separate meaningful results from wasted effort
So now the question is how the heck do I know that if my shoulder starts feeling better or has better mobility, it's because of the peptides